ST. JUDE TO FILL OUT CARDIAC RHYTHM MANAGEMENT LINE WITH VENTRITEX MERGER; TELECTRONICS BUY, INTERMEDICS LICENSE CLEAR PACT'S PATENT OBSTACLES
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical entered a pair of merger agreements and a patent settlement to add Ventritex' implantable cardioverter defibrillator product line to its cardiac rhythm management device stable.